ITRM910085A0 - Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo. - Google Patents

Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo.

Info

Publication number
ITRM910085A0
ITRM910085A0 IT91RM85A ITRM910085A ITRM910085A0 IT RM910085 A0 ITRM910085 A0 IT RM910085A0 IT 91RM85 A IT91RM85 A IT 91RM85A IT RM910085 A ITRM910085 A IT RM910085A IT RM910085 A0 ITRM910085 A0 IT RM910085A0
Authority
IT
Italy
Prior art keywords
ovarian
cancers
therapy
those
active ingredient
Prior art date
Application number
IT91RM85A
Other languages
English (en)
Inventor
Salvatore Mancuso
Giovanni Scambia
Pier Luigi Benedetti-Panici
Mauro Piantelli
Franco Oreste Ranelletti
Arnaldo Capelli
Giancarlo Folchitto
Original Assignee
Salvatore Mancuso
Romeo Francesco
Dalla Costa Giorgio
Giancarlo Folchitto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salvatore Mancuso, Romeo Francesco, Dalla Costa Giorgio, Giancarlo Folchitto filed Critical Salvatore Mancuso
Priority to ITRM910085A priority Critical patent/IT1244647B/it
Publication of ITRM910085A0 publication Critical patent/ITRM910085A0/it
Priority to EP92905230A priority patent/EP0570475A1/en
Priority to JP4505072A priority patent/JPH07502009A/ja
Priority to AU12691/92A priority patent/AU1269192A/en
Priority to PCT/IT1992/000007 priority patent/WO1992013851A1/en
Publication of ITRM910085A1 publication Critical patent/ITRM910085A1/it
Application granted granted Critical
Publication of IT1244647B publication Critical patent/IT1244647B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITRM910085A 1991-02-05 1991-02-05 Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo. IT1244647B (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ITRM910085A IT1244647B (it) 1991-02-05 1991-02-05 Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo.
EP92905230A EP0570475A1 (en) 1991-02-05 1992-01-31 Pharmaceutical preparation for the therapy of tumors, particularly ovarian and haemopoietic system tumors, containing quercetin compounds as active substances
JP4505072A JPH07502009A (ja) 1991-02-05 1992-01-31 クエルセチン化合物を活性物質として含有する腫瘍、特に卵巣及び造血系の腫瘍の治療用薬剤
AU12691/92A AU1269192A (en) 1991-02-05 1992-01-31 Pharmaceutical product for the therapy of tumors, particularly ovarian and haemopoietic system tumors, containing quercetin compounds as active substances
PCT/IT1992/000007 WO1992013851A1 (en) 1991-02-05 1992-01-31 Pharmaceutical product for the therapy of tumors, particularly ovarian and haemopoietic system tumors, containing quercetin compounds as active substances

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM910085A IT1244647B (it) 1991-02-05 1991-02-05 Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo.

Publications (3)

Publication Number Publication Date
ITRM910085A0 true ITRM910085A0 (it) 1991-02-05
ITRM910085A1 ITRM910085A1 (it) 1992-08-05
IT1244647B IT1244647B (it) 1994-08-08

Family

ID=11399834

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM910085A IT1244647B (it) 1991-02-05 1991-02-05 Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo.

Country Status (5)

Country Link
EP (1) EP0570475A1 (it)
JP (1) JPH07502009A (it)
AU (1) AU1269192A (it)
IT (1) IT1244647B (it)
WO (1) WO1992013851A1 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20010600A1 (it) * 2001-10-04 2003-04-04 Brane Tech S R L Composti flavonoidici capaci di modificare lo stato fisico e/o dinamico di membrane biologiche e di stimolare la sintesi endogena di protein
MX347014B (es) * 2010-11-24 2017-04-07 Durect Corp Composición para administración de fármaco biodegradable.
JP6825809B2 (ja) 2012-11-26 2021-02-10 アクセス ビジネス グループ インターナショナル リミテッド ライアビリティ カンパニー 抗酸化栄養補助食品と、それに関連する方法
CN111068095B (zh) * 2020-02-07 2021-07-13 中国科学院上海硅酸盐研究所 高效诱导烧伤创面毛囊再生的生物活性离子改性槲皮素螯合剂组合物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2892845A (en) * 1957-11-26 1959-06-30 Jurd Leonard Selective etherification of the 7-hydroxyl group in polyhydroxy flavonoids
FR3541M (fr) * 1964-05-12 1965-09-13 Laroche Navarron Lab Médicament a propriétés natriurétiques a base d'une nouvelle flavone.

Also Published As

Publication number Publication date
EP0570475A1 (en) 1993-11-24
JPH07502009A (ja) 1995-03-02
ITRM910085A1 (it) 1992-08-05
IT1244647B (it) 1994-08-08
AU1269192A (en) 1992-09-07
WO1992013851A1 (en) 1992-08-20

Similar Documents

Publication Publication Date Title
DE3681755D1 (de) Wirkstofftraeger und diesen enthaltende arzneimittel.
NL194239B (nl) Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten.
AU649421B2 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs
BG101118A (en) Therapeutical compounds
FR2677984B1 (fr) Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
NO944700D0 (no) Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene
HUT51269A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
NL8601838A (nl) Distamycinederivaten, werkwijze voor de bereiding ervan, alsmede farmaceutische preparaten, die deze derivaten bevatten.
EP0620004A4 (en) MEDICAL COMPOSITION.
FR2681067B1 (fr) Derives heterocycliques n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
IT8584151A0 (it) Procedimento per la sanitizzazione di contenitori e materiali di confezionamento, particolarmente per uso farmaceutico e cosmetico, ed impianto per effettuare il procedimento.
FR2663326B2 (fr) Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
NL191307C (nl) Analgetisch werkzame piperazinederivaten en farmaceutische preparaten, die deze derivaten bevatten.
TW290455B (it)
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
ITRM910085A0 (it) Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo.
IL105276A0 (en) Pyridine derivative,its production and pharmaceutical compositions containing it
DE3874390D1 (de) Carboxystyrol-derivate und arzneimittel, die sie als wirkstoff enthalten.
HU9201358D0 (en) 2-amino-pirimidine-4-carboxamide derivatives, process for their production and for the production of medical preparations containing them as active agents
IT8519907A0 (it) Prodotto farmaceutico cosmetico, in particolare per la cura di acne e seborrea.
IT8220356A0 (it) Guanidino eterociclifenilamidine, processi per la loro preparazione e loro impiego farmaceutico.
GR3019776T3 (en) Antineoplastic medicament containing octadecyl-[2-(N-methylpiperidino)-ethyl] phosphate and synthesis thereof
CA2113080A1 (en) Topical composition containing penciclovir
ZA928127B (en) Use of substituted pyrrolidines, some of which are known, as medicaments, new active substances and processes for their preparation.
ITRM910155A0 (it) Preparati farmaceutici per la terapia dei tumori contenenti colchicina come principio attivo e metodi per l'impiego degli stessi.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960215